1674P NT-I7 plus pembrolizumab combination treatment enhances infiltration of PD-1+ T cells and provides a more immunogenic tumor microenvironment: Biomarker data from the NIT-110 study
Naing, A., Ferrando-Martinez, S., Wolfarth, A., Xu, M., Goon, J.B., Ware, M.B., Haymaker, C., Raso, M.G., Chaney, M., Ezeanya, U.I., Dhar, S., Lee, H., Lee, T., Adebanjo, T., Fan, J., Yang, S.H., Lee, B.H., Kim, R.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article